Patents by Inventor David Lough

David Lough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mass spectrometric detection of polypeptides
    Publication number: 20030003465
    Abstract: A process for ascertain sequence information about a nucleic acid molecule by determining the identity of a polypeptide using mass spectroscopy is provided. Depending on the polypeptide to be identified, a process as disclosed is used, for example, to diagnose a genetic disease or chromosomal abnormality, a predisposition to a disease or condition, or infection by a pathogenic organism; or for determining identity or heredity. Kits for performing the disclosed processes also are provided.
    Type: Application
    Filed: November 6, 2001
    Publication date: January 2, 2003
    Inventors: Daniel Little, Hubert Koster, G. Scott Higgins, David Lough
  • Mass spectrometric detection of polypeptides
    Patent number: 6387628
    Abstract: A process for determining the identity of a target polypeptide using mass spectroscopy is provided. Depending on the target polypeptide to be identified, a process as disclosed can be used, for example, to diagnose a genetic disease or chromosomal abnormality, a predisposition to a disease or condition, or infection by a pathogenic organism; or for determining identity or heredity. Kits for performing the disclosed processes also are provided.
    Type: Grant
    Filed: September 18, 2000
    Date of Patent: May 14, 2002
    Assignee: Sequenom, Inc.
    Inventors: Daniel Little, Hubert Köster, G. Scott Higgins, David Lough
  • Mass spectrometric detection of polypeptides
    Patent number: 6322970
    Abstract: A process for determining the identity of a target polypeptide using mass spectroscopy is provided. Depending on the target polypeptide to be identified, a process as disclosed can be used, for example, to diagnose a genetic disease or chromosomal abnormality, a predisposition to a disease or condition, or infection by a pathogenic organism; or for determining identity or heredity. Kits for performing the disclosed processes also are provided.
    Type: Grant
    Filed: September 2, 1998
    Date of Patent: November 27, 2001
    Assignee: Sequenom, Inc.
    Inventors: Daniel Little, Hubert Köster, G. Scott Higgins, David Lough